351 related articles for article (PubMed ID: 24666931)
1. Comparison of the modified shuttle walk test and cardiopulmonary exercise test in sarcoidosis.
de Boer S; Kolbe J; Wilsher ML
Respirology; 2014 May; 19(4):604-7. PubMed ID: 24666931
[TBL] [Abstract][Full Text] [Related]
2. Six-minute walk distance and work relationship with incremental treadmill cardiopulmonary exercise test in COPD.
Poersch K; Berton DC; Canterle DB; Castilho J; Lopes AL; Martins J; Oliveira AR; Teixeira PJ
Clin Respir J; 2013 Apr; 7(2):145-52. PubMed ID: 22524795
[TBL] [Abstract][Full Text] [Related]
3. Estimating exercise capacity from walking tests in elderly individuals with stable coronary artery disease.
Mandic S; Walker R; Stevens E; Nye ER; Body D; Barclay L; Williams MJ
Disabil Rehabil; 2013; 35(22):1853-8. PubMed ID: 23600709
[TBL] [Abstract][Full Text] [Related]
4. Incremental shuttle walking test: a reproducible and valid test to evaluate exercise tolerance in adults with noncystic fibrosis bronchiectasis.
de Camargo AA; Amaral TS; Rached SZ; Athanazio RA; Lanza FC; Sampaio LM; de Carvalho CR; Cukier A; Stelmach R; Dal Corso S
Arch Phys Med Rehabil; 2014 May; 95(5):892-9. PubMed ID: 24361325
[TBL] [Abstract][Full Text] [Related]
5. The body weight-walking distance product as related to lung function, anaerobic threshold and peak VO2 in COPD patients.
Chuang ML; Lin IF; Wasserman K
Respir Med; 2001 Jul; 95(7):618-26. PubMed ID: 11453321
[TBL] [Abstract][Full Text] [Related]
6. Validity and reliability of the modified shuttle walk test in patients with chronic obstructive pulmonary disease.
Campo LA; Chilingaryan G; Berg K; Paradis B; Mazer B
Arch Phys Med Rehabil; 2006 Jul; 87(7):918-22. PubMed ID: 16813778
[TBL] [Abstract][Full Text] [Related]
7. Quantitative evaluation of cardiopulmonary functional reserve in treated patients with pulmonary embolism.
Yan WW; Wang LM; Che L; Song HM; Jiang JF; Xu JH; Shen YQ; Zhang QP
Chin Med J (Engl); 2012 Feb; 125(3):465-9. PubMed ID: 22490404
[TBL] [Abstract][Full Text] [Related]
8. [Cardiopulmonary exercise capacity in adult patients with atrial septal defect].
Suchoń E; Podolec P; Tomkiewicz-Pajak L; Kostkiewicz M; Mura A; Pasowicz M; Tracz W
Przegl Lek; 2002; 59(9):747-51. PubMed ID: 12632902
[TBL] [Abstract][Full Text] [Related]
9. Comparing peak and submaximal cardiorespiratory responses during field walking tests with incremental cycle ergometry in COPD.
Hill K; Dolmage TE; Woon L; Coutts D; Goldstein R; Brooks D
Respirology; 2012 Feb; 17(2):278-84. PubMed ID: 22008290
[TBL] [Abstract][Full Text] [Related]
10. Spirometry, cardiopulmonary exercise testing and the six-minute walk test results in sarcoidosis patients.
Kiani A; Eslaminejad A; Shafeipour M; Razavi F; Seyyedi SR; Sharif-Kashani B; Emami H; Bakhshayesh-Karam M; Abedini A
Sarcoidosis Vasc Diffuse Lung Dis; 2019; 36(3):185-194. PubMed ID: 32476953
[TBL] [Abstract][Full Text] [Related]
11. Measurement properties of the 6-min walk test in individuals with exercise-induced pulmonary arterial hypertension.
Fowler RM; Jenkins SC; Maiorana AJ; Gain KR; O'Driscoll G; Gabbay E
Intern Med J; 2011 Sep; 41(9):679-87. PubMed ID: 21470356
[TBL] [Abstract][Full Text] [Related]
12. Reduction of maximal oxygen uptake in sarcoidosis: relationship with disease severity.
Wallaert B; Talleu C; Wemeau-Stervinou L; Duhamel A; Robin S; Aguilaniu B
Respiration; 2011; 82(6):501-8. PubMed ID: 21934275
[TBL] [Abstract][Full Text] [Related]
13. Which field walking test should be used to assess functional exercise capacity in lung cancer? An observational study.
Granger CL; Denehy L; Parry SM; Martin J; Dimitriadis T; Sorohan M; Irving L
BMC Pulm Med; 2015 Aug; 15():89. PubMed ID: 26264470
[TBL] [Abstract][Full Text] [Related]
14. Physiological responses to maximal exercise testing and the modified incremental shuttle walk test in adults after thermal injury: a pilot study.
Stockton KA; Davis MJ; Brown MG; Boots R; Paratz JD
J Burn Care Res; 2012; 33(2):252-8. PubMed ID: 21983649
[TBL] [Abstract][Full Text] [Related]
15. Comparison of shuttle walk with measured peak oxygen consumption in patients with operable lung cancer.
Win T; Jackson A; Groves AM; Sharples LD; Charman SC; Laroche CM
Thorax; 2006 Jan; 61(1):57-60. PubMed ID: 16244091
[TBL] [Abstract][Full Text] [Related]
16. Peak exercise capacity estimated from incremental shuttle walking test in patients with COPD: a methodological study.
Arnardóttir RH; Emtner M; Hedenström H; Larsson K; Boman G
Respir Res; 2006 Oct; 7(1):127. PubMed ID: 17044921
[TBL] [Abstract][Full Text] [Related]
17. The 1-Minute Sit-to-Stand Test in Adults With Cystic Fibrosis: Correlations With Cardiopulmonary Exercise Test, 6-Minute Walk Test, and Quadriceps Strength.
Gruet M; Peyré-Tartaruga LA; Mely L; Vallier JM
Respir Care; 2016 Dec; 61(12):1620-1628. PubMed ID: 27899540
[TBL] [Abstract][Full Text] [Related]
18. Opposite behavior of plasma levels surfactant protein type B and receptor for advanced glycation end products in pulmonary sarcoidosis.
Magrì D; Mariotta S; Banfi C; Ricotta A; Onofri A; Ricci A; Pisani L; Cauti FM; Ghilardi S; Agostoni P
Respir Med; 2013 Oct; 107(10):1617-24. PubMed ID: 23948664
[TBL] [Abstract][Full Text] [Related]
19. Is there an added value of cardiopulmonary exercise testing in sarcoidosis patients?
Marcellis RG; Lenssen AF; de Vries GJ; Baughman RP; van der Grinten CP; Verschakelen JA; De Vries J; Drent M
Lung; 2013 Feb; 191(1):43-52. PubMed ID: 23138855
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary function at peak exercise in patients with chronic heart failure.
Papazachou O; Anastasiou-Nana M; Sakellariou D; Tassiou A; Dimopoulos S; Venetsanakos J; Maroulidis G; Drakos S; Roussos C; Nanas S
Int J Cardiol; 2007 May; 118(1):28-35. PubMed ID: 16893579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
